A single intradiscal injection of allogeneic NP reduced chronic lumbar discogenic pain and improved function at 12 months, ...

"We were pleased that blinded data from the ongoing Phase 2 trial of BRTX-100 in cLDD continues to be in-line to meet the primary safety endpoint of study, and that the positive preliminary efficacy ...

Following recent approvals in the EU, US and China, the Singapore approval is based on two replicate phase 3 studies that showed Dupixent achieved significant reduction in exacerbations, and also ...

BioRestorative Therapies, Inc. ("BioRestorative", "BRTX" or the "Company") (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on ...

After Bindi Irwin canceled her appearance at the Steve Irwin Gala due to a medical emergency, the 26-year-old shared that she ...